Aiteweisi (Foshan) is an enterprise integrating production, sales and sales. Marketing and research and development. Atvis Group's R&D base in China. The earliest predecessor of Atevis (Foshan) was Foshan Pharmaceutical Factory, which was founded in 1958, acquired by FH Faulding of Australia in 1994, and acquired by Alpharma of the United States in 200 1 year. Aiteweis (Foshan) became a part of Aiteweis Group at the end of 2005, and its official name was Aiteweis (Foshan) Pharmaceutical Co., Ltd. Aitevis Group is a pharmaceutical company headquartered in New Jersey, USA. It is one of the top 50 pharmaceutical companies and the third largest generic drug company in the world. Its business covers more than 60 countries or regions around the world. At present, more than 1000 kinds of products are produced and sold, and more than 600 kinds of products are being developed and registered, involving central nervous system, digestion, cardiovascular system, metabolism, anti-infection, respiration and other fields.
Aitevis (Foshan) Pharmaceutical Co., Ltd. is the R&D production and sales base of Aitevis Group in China. Its predecessor was Foshan Pharmaceutical Factory, which was established in 1960. After passing through Australia Kangbaoshun (Foshan) Pharmaceutical Co., Ltd. and America Yalai (Foshan) Pharmaceutical Co., Ltd., it developed into Aitevis (Foshan) Pharmaceutical Co., Ltd. at the end of 2005. Atvis adheres to the highest standards of R&D production and service. We welcome to provide customers with good drugs of "EU quality and China price" together with national distributors. As an important part of the development strategy of Avis Group, Chinese mainland business will surely make great contributions to the Group's becoming a better generic drug enterprise.